Document › Details

Renaissance Capital. (3/22/19). "News: Cancer Biotech Hookipa Pharma Files for a $86 Million IPO".

Region Region United States (USA)
Organisations Organisation Hookipa Pharma Inc. (Nasdaq: HOOK)
  Group Hookipa (Group)
  Organisation 2 Nasdaq
  Group Nasdaq OMX (Group)
Products Product T cell therapy
  Product 2 investment banking
Index term Index term Hookipa–SEVERAL: investment, 201903–201904 IPO $84m+$12.6m with 6m+900k shares common stock at Nasdaq Global Select Market
     


   
Record changed: 2019-03-24

Advertisement

Picture [LSUK] Life-Sciences-UK.com – The Business Web Portal 650x99px

More documents for Hookipa (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Advertisement

Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 600x60px




» top